Abstract
P‐CB‐2 | Amotosalen/UVA Treatment of Platelet and Plasma Components using the INTERCEPT Blood Systems to Inactivate WHO Reference Bacterial Strains
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have